# Combination Chemotherapy in Treating Patients With Bladder Cancer

> **NCT00003701** · PHASE3 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 490 (estimated)

## Conditions studied

- Bladder Cancer
- Urethral Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** methotrexate
- **DRUG:** paclitaxel
- **DRUG:** vinblastine sulfate

## Key facts

- **NCT ID:** NCT00003701
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04-02
- **Primary completion:** 2001-08
- **Final completion:** 2007-06-15
- **Target enrollment:** 490 (ESTIMATED)
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003701, "Combination Chemotherapy in Treating Patients With Bladder Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*